XP (XP) Earnings Analysis
XP (XP) next reports earnings on 2026-08-17, consensus EPS 0.51 USD. Last quarter (2026-05-18) it missed with EPS 0.47 USD vs 0.4873 USD est (-3.6%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E 8.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does XP next report earnings?
| Next earnings date | 2026-08-17 |
|---|---|
| Consensus EPS estimate | 0.51 USD |
| Revenue estimate | 0.93B |
XP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-18 | 0.47 USD | 0.4873 USD | -3.6% | Miss |
| 2026-02-12 | 0.46 USD | 0.45 USD | +2.2% | Beat |
| 2025-11-17 | 0.45 USD | 0.457 USD | -1.5% | Miss |
| 2025-08-18 | 0.43 USD | 0.4298 USD | 0% | Beat |
| 2025-05-20 | 0.39 USD | 0.4 USD | -2.5% | Miss |
| 2025-02-18 | 0.38 USD | 0.3556 USD | +6.9% | Beat |
| 2024-11-19 | 0.39 USD | 0.38 USD | +2.6% | Beat |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
XP valuation and analyst view
| Trailing P/E | 8.77 |
|---|---|
| Trailing EPS | 9.965 USD |
| Price / book | 1.86 |
| Dividend yield | 2.20% |
| Market cap | 8.94B |
| Analyst consensus | Buy (7 buy / 2 hold / 0 sell) |
| Avg price target | 23.33 USD |
Related research pages
Frequently asked questions
When is XP (XP)'s next earnings date?
XP is next scheduled to report on 2026-08-17, with a consensus EPS estimate of 0.51 USD and revenue estimate of 0.93B.
Did XP beat earnings last quarter?
In its 2026-05-18 report, XP posted EPS of 0.47 USD versus a 0.4873 USD estimate — a miss of 3.6%.
What is XP's earnings track record?
Over the last 7 reported quarters with consensus data, XP beat estimates 4 times (57%).
What is XP's current P/E ratio and EPS?
XP trades at a trailing P/E of 8.77 on trailing EPS of 9.96490705693139 USD.
What do analysts rate XP?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 23.33 USD.